NASDAQ:LIFE
aTyr Pharma Stock News
$1.60
+0.0100 (+0.629%)
At Close: May 02, 2024
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Atyr Pharma (LIFE) Q1 Earnings and Revenues Surpass Estimates
09:25pm, Tuesday, 12'th May 2020
Atyr Pharma (LIFE) delivered earnings and revenue surprises of 238.89% and 83.30%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Atyr Pharma: 1Q Earnings Snapshot
08:20pm, Tuesday, 12'th May 2020
SAN DIEGO (AP) _ Atyr Pharma Inc. (LIFE) on Tuesday reported first-quarter net income of $1.8 million, after reporting a loss in the same period a year earlier. The San Diego-based company...
SAN DIEGO, May 12, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
aTyr Pharma to Webcast Conference Call Reporting First Quarter 2020 Financial Results
12:03pm, Wednesday, 06'th May 2020
SAN DIEGO, May 06, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel.
aTyr Pharma Announces Publication of Two Abstracts in American Journal of Respiratory and Critical Care Medicine
12:03pm, Tuesday, 05'th May 2020
SAN DIEGO, May 05, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways
Oppenheimer Remains a Buy on aTyr Pharma (LIFE)
10:44am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on aTyr Pharma (LIFE – Research Report) today and set a price
SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathwa
NEW YORK, NY / ACCESSWIRE / April 13, 2020 / Levi & Korsinsky announces it has commenced an investigation of aTyr Pharma, Inc. (NASDAQ:LIFE) concerning possible breaches of fiduciary duty. To obtain a
The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance
12:02pm, Friday, 27'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.None of the NYSE- or Nasdaq-listed biotech stocks hit 52 week highs Thursday.Down In The Dumps (Biotech Stocks Hitting
Atyr Pharma (LIFE) Reports Q4 Loss, Beats Revenue Estimates (Revised)
11:35am, Friday, 27'th Mar 2020
Atyr Pharma (LIFE) delivered earnings and revenue surprises of 3.14% and 69.41%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Oppenheimer Maintains a Buy Rating on aTyr Pharma (LIFE)
11:32am, Friday, 27'th Mar 2020
Oppenheimer analyst
Hartaj Singh
maintained a
Buy
rating on aTyr Pharma (
LIFE
–
Research Report
) today and set a price target of
$8.00
. The company’s shares closed last Monday at $3.08, close t
aTyr Pharma Announces Fourth Quarter and Full Year 2019 Results and Provides Corporate Update
08:01pm, Thursday, 26'th Mar 2020
Company to host conference call and webcast today at 5:00 p.m. EDT / 2:00 p.m. PDT SAN DIEGO, March 26, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company.
